glp 1 patches vs shot Things to Know About GLP-1 If you've been wanting to

In August 2025, the FDA approved Wegovy to treat MASH, also known as nonalcoholic steatohepatitis, in adults with moderate to advanced fibrosis

Nat Rev Nephrol 12(2):7381 Muskiet MHA, Tonneijck L, Smits MM, Kramer MHH, Heerspink HJL, van Raalte DH (2015) Pleiotropic effects of type 2 diabetes management strategies on renal risk factors

This widespread distribution means GLP-1 affects multiple systems simultaneously

GLP-1 receptor agonists such as exenatide, liraglutide, semaglutide, and dulaglutide are already approved for treating Type 2 diabetes mellitus and obesity, which interests researchers in further research